Shanghai Desano Chemical Pharmaceutical is an API manufacturer based in China. It holds 32 active US drug master files and 10 valid CEPs. Its GMP standing is certified by MHRA (UK) and US FDA. Its most recent recorded inspection, by US FDA, closed on 17 November 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Laogang Town, China | Not on file |
| SHANGHAI, China | Not on file |
| China, China | 3006895951 |
| Molecule | Regulators | Docs |
|---|---|---|
| Lamivudine | EDQM, US FDA | 3 |
| Ritonavir | EDQM, US FDA | 3 |
| Atazanavir | EDQM, US FDA | 2 |
| Lopinavir | US FDA | 2 |
| Nevirapine | EDQM, US FDA | 2 |
| Praziquantel | EDQM, US FDA | 2 |
| Zidovudine | EDQM, US FDA | 2 |
| Abacavir | EDQM | 1 |
| Atovaquone | US FDA | 1 |
| Cabotegravir | US FDA | 1 |
| Canagliflozin | US FDA | 1 |
| Dolutegravir | US FDA | 1 |
| Dotinurad | US FDA | 1 |
| Edoxaban | US FDA | 1 |
| Efavirenz | US FDA | 1 |
| Elagolix | US FDA | 1 |
| Eltrombopag | US FDA | 1 |
| Elvitegravir | US FDA | 1 |
| Emtricitabine | US FDA | 1 |
| Finerenone | US FDA | 1 |
| Isavuconazonium | US FDA | 1 |
| Lasmiditan | US FDA | 1 |
| Letermovir | US FDA | 1 |
| Lumefantrine | US FDA | 1 |
| Omadacycline | US FDA | 1 |
| Oseltamivir | US FDA | 1 |
| Raltegravir | EDQM | 1 |
| Rilpivirine | US FDA | 1 |
| Rosuvastatin | US FDA | 1 |
| Tedizolid | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| BOMRA (BW) | 1 | None |
| MHRA (UK) | None | 3 |
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Shanghai Desano Chemical Pharmaceutical, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.